Espec Corp.
Notice Regarding Share Buyback and Termination of Buyback
Disclosure of the status of treasury stock acquisition through market purchases. Total issued: 95,400 shares, total acquisition value: 387,192,989 yen, period: July 1, 2026 to July 30, 2026, method: market purchases. The framework of up to 900,000 shares and up to 3.5 billion yen decided at the November 13, 2025 board meeting remains, but this time the buyback is announced as completed.
Key Figures
- Total number of shares acquired: 95,400 shares
- Total acquisition value: 387,192,989 yen
- Acquisition period: July 1, 2026 to July 30, 2026
AI要約
Overview of capital policy
We disclosed the status of treasury stock acquisition in accordance with Corporate Law Article 165. The acquisition period is from July 1, 2026 to July 30, 2026, implemented by market purchases, and the acquired shares are common stock. Consequently, the framework of up to 900,000 shares and up to 3.5 billion yen decided at the November 13, 2025 meeting of the Board is considered closed.
Impact on investors and future
The number of shares acquired is 95,400 shares, total amount about 387 million yen. As part of anti-dilution measures and shareholder value return strategies, treasury stock acquisitions have progressed, and with this termination the series of capital policy actions has been disclosed as completed. Going forward, details of capital policy trends are unknown, and no further disclosures are anticipated.
Espice Co., Ltd.
Company overview · Stock price · Financial data · All IR
